why choose us

First received: January 18, 2023

Clinical Trial: Vasoactive-inotropic Support and Levosimendan Use After Lung Transplantation

Study Status: Completed

Recruit Status: Completed

Condition: Lung Transplant; Complications

Study Type: Observational


Official Title: Postoperative Prolonged Vasoactive-inotropic Support and Levosimendan Use After Lung Transplantation: a Retrospective Analysis of Risk Factors and Impact on Outcomes

Brief Summary: Bilateral Lung transplantation (LUTX) is performed in selected patients with end-stage respiratory failure. During surgery, pulmonary arteries are sequentially cross-clamped. This can cause acute heart failure and hemodynamic instability that eventually persist into the postoperative period, leading to the need for prolonged vasoactive support in the postoperative Intensive Care Unit. Levosimendan is a relatively new vasoactive-inotropic drug, with different pharmacodynamic properties.This observational…

Read more